Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6 Myelodysplastic Syndromes 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Leukemia, Myeloid, Acute 4 Graft vs Host Disease 4 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Myocarditis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Arthritis 1 Anemia, Refractory 1

Interventions

Tomography, X-Ray Computed 1 Positron-Emission Tomography 1 Positron Emission Tomography Computed Tomography 1 Hypnosis 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myocarditis × Abatacept × Clear all

NCT05335928 2025-09-10

ATRIUM

Massachusetts General Hospital

Phase 3 Recruiting

Myocarditis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡